The field of genetic testing is expanding and evolving at an incredible rate, thanks to our growing knowledge of genetic conditions, dropping costs, and higher demand.
This rapid expansion has dramatically changed how we diagnose and screen for genetic conditions, who we test, and how informative the results are. Learning about the recent advances in genetic testing and sequencing technologies has important implications for anyone working in health care and related sectors.
This course offers a unique way for professionals to learn about genetic testing and its applications from leading Harvard Medical School faculty.
Unless otherwise specifically stated in relation to each and any of the events listed on this page, the MLSC does not host or sponsor these events. The MLSC has no oversight or responsibility for the venue, content or host-organization related to these events. The MLSC has no affiliation with the organizations listing events or with the events, and provides this content and information as a convenience to visitors to the MLSC website.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.